G9019 is a valid 2023 HCPCS Code that could be used to indicate Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project) for reimbursement purposes.
G9019 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2020.
Oseltamivir phosphate 75mg
G9019 code information
| HCPCS code: | G9019 |
| Description: | OSELTAMIVIR PHOSPHATE, ORAL, PER 75 MG (FOR USE IN A MEDICARE-APPROVED DEMONSTRATION PROJECT) |
| Effective Date: | Jan 01, 2020 |
| Added Date: | Dec 01, 2004 |
| Termination Date: | HCPCS G9019 was terminated on Dec 31, 2019 |
| Pricing indicator: | 13 - PRICE ESTABLISHED BY CARRIERS (E.G., NOT OTHERWISE CLASSIFIED, INDIVIDUAL DETERMINATION, CARRIER DISCRETION) |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to G9019